Maintaining effective treatment in dementia: A case series on patients switched to rivastigmine

Carl Sadowsky, Keith Edwards, Bijan Etemad, Martin Farlow

Research output: Contribution to journalArticle

Abstract

In the clinical management of Alzheimer's disease (AD), switching cholinesterase (ChE) inhibitors is becoming an increasingly common practice following non-response or safety/tolerability problems with an initial agent. Data from clinical studies has demonstrated that approximately half of all patients benefit from switching. In this paper, we present eight case studies from our own clinical experience of switching ChE inhibitors, and highlight some of the potential benefits associated with this practice.

Original languageEnglish (US)
Pages (from-to)71-75
Number of pages5
JournalPrimary Care Psychiatry
Volume9
Issue number3
DOIs
StatePublished - Dec 1 2004

Keywords

  • Alzheimer's disease
  • Cholinesterase inhibitors
  • Rivastigmine
  • Switching

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Maintaining effective treatment in dementia: A case series on patients switched to rivastigmine'. Together they form a unique fingerprint.

  • Cite this